The MNOV chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MNOV chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The MNOV stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View MNOV Detailed Price Forecast - CNN Money||View MNOV Detailed Summary - Google Finance|
|View MNOV Detailed Summary - Yahoo! Finance||View MNOV Stock Research & Analysis - Zacks.com|
|View MNOV Trends & Analysis - Trade-Ideas||View MNOV Major Holders - Barrons|
|View MNOV Call Transcripts - NASDAQ||View MNOV Breaking News & Analysis - Seeking Alpha|
|View MNOV Annual Report - CompanySpotlight.com||View MNOV OTC Short Report - OTCShortReport.com|
|View MNOV Fundamentals - TradeKing||View MNOV SEC Filings - Bar Chart|
|View Historical Prices for MNOV - The WSJ||View Performance/Total Return for MNOV - Morningstar|
|View the Analyst Estimates for MNOV - MarketWatch||View the Earnings History for MNOV - CNBC|
|View the MNOV Earnings - StockMarketWatch||View MNOV Buy or Sell Recommendations - MacroAxis|
|View the MNOV Bullish Patterns - American Bulls||View MNOV Short Pain Metrics - ShortPainBot.com|
|View MNOV Stock Mentions - StockTwits||View MNOV Stock Mentions - PennyStockTweets|
|View MNOV Stock Mentions - Twitter||View MNOV Investment Forum News - Investor Hub|
|View MNOV Stock Mentions - Yahoo! Message Board||View MNOV Stock Mentions - Seeking Alpha|
|View Insider Transactions for MNOV - SECform4.com||View Insider Transactions for MNOV - Insider Cow|
|View MNOV Major Holdings Summary - CNBC||View Insider Disclosure for MNOV - OTC Markets|
|View Insider Transactions for MNOV - Yahoo! Finance||View Institutional Holdings for MNOV - NASDAQ|
|View MNOV Stock Insight & Charts - FinViz.com||View MNOV Investment Charts - StockCharts.com|
|View MNOV Stock Overview & Charts - BarChart||View MNOV User Generated Charts - Trading View|
Want To Invest In MediciNova Inc (NASDAQ:MNOV)? Here’s How It Performed Lately
Posted on Wednesday May 16, 2018
After reading MediciNova Inc’s (NASDAQ:MNOV) most recent earnings announcement (31 March 2018), I found it useful to look back at how the company has performed in the past and compareRead More...
MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma
Posted on Wednesday May 09, 2018
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced that the Investigational New Drug Application (IND) for MN-166 (ibudilast) for treatment of glioblastoma (GBM) has been accepted and is now open with the U.S. Food and Drug Administration (FDA). MediciNova was informed by the FDA that the proposed clinical investigation of MN-166 (ibudilast) in combination with temozolomide (TMZ) for treatment of GBM may proceed.
MediciNova to Present at the UBS Global Healthcare Conference in New York
Posted on Tuesday May 08, 2018
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced that MediciNova will present a corporate overview at the UBS Global Healthcare Conference on Monday, May 21, 2018 at 9:00 am at the Grand Hyatt New York in New York City. Yuichi Iwaki, MD, PhD, President and Chief Executive Officer, and Geoffrey O'Brien, JD/MBA, Vice President and Executive Officer, will be available for one-on-one meetings at this conference and investors may request a one-on-one meeting through UBS. MediciNova, Inc. is a publicly-traded biopharmaceutical company founded on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with high unmet medical needs with a primary commercial focus on the U.S. market.
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it plans to initiate a clinical trial of MN-166 (ibudilast) in alcohol dependence and withdrawal in collaboration with researchers at the University of California, Los Angeles (UCLA).